Salix Coronary Plaque vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Salix Coronary Plaque
by Artrya
VS
Viz HCM
by Viz.ai

AI Verdict

While both tools leverage AI in cardiology, they address distinct conditions and utilize different diagnostic modalities. Salix Coronary Plaque focuses on detecting and quantifying coronary artery plaque and stenosis from CCTA scans for Coronary Artery Disease, whereas Viz HCM uses ECG analysis to detect suspected Hypertrophic Cardiomyopathy and coordinate care. Therefore, their applicability depends on the specific cardiac condition being investigated.

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if your institution requires an AI-driven, web-based solution for the rapid and comprehensive analysis of CCTA scans. This tool is ideal for cardiologists and radiologists seeking near real-time, point-of-care assessment of coronary artery plaque, including high-risk features and stenosis, to inform immediate diagnostic and treatment strategies for coronary artery disease.

View Salix Coronary Plaque →

Choose Viz HCM if…

Choose Viz HCM if your primary goal is the early and efficient detection of suspected Hypertrophic Cardiomyopathy (HCM) from routine ECGs across your health system. This AI-powered tool excels at real-time identification of potential HCM cases, automating alerts to multidisciplinary care teams and streamlining patient pathways to specialists, thereby significantly reducing diagnosis time and improving care coordination for this specific condition.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Salix Coronary Plaque Viz HCM
Pricing Subscription model Unknown
Deployment Cloud-based (Amazon Web Services), web-based software application Unknown
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Salix Coronary Plaque Viz HCM
Product Name Salix Coronary Plaque Viz HCM
Company Artrya Limited Viz.ai
Primary Function AI-driven, web-based software for near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans. AI tool using real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care.
Specialties Cardiology, Radiology Cardiology, Emergency Medicine, Hospital Medicine
Key Features (Examples) AI-enabled CCTA analysis, Near real-time, point-of-care assessment, Detection and quantification of coronary plaque AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection, Real-time disease detection from electrocardiograms, Mobile-based alerts and notifications

Videos

Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Viz HCM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Salix Coronary Plaque is designed for the assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the diagnosis of coronary artery disease. Viz HCM uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM).
Salix Coronary Plaque analyzes CCTA scans to provide its assessment of coronary artery plaque and stenosis. Viz HCM utilizes real-time 12-lead ECG analysis for the detection of suspected Hypertrophic Cardiomyopathy.
Salix Coronary Plaque operates on a per-scan assessment model with a US CPT reimbursement rate of US$950 per assessment, effective January 1, 2026. Viz HCM is subscription-based for hospitals and health systems, with CMS reimbursement available for CPT codes 0764T and 0765T at a national payment rate of $128.90, effective January 1, 2025.
Salix Coronary Plaque is a web-based, cloud deployment software that provides near real-time, point-of-care assessment. Viz HCM is a cloud-based platform designed for seamless integration with existing clinical workflows, EHR, and PACS systems, providing real-time alerts and notifications.
Salix Coronary Plaque offers AI-enabled CCTA analysis for detection and quantification of coronary plaque, identification of high-risk plaque features, stenosis assessment, and automated report generation. Viz HCM provides AI-powered ECG analysis for HCM detection, real-time mobile alerts to multidisciplinary care teams, automated patient direction to specialists, and aims to reduce time to diagnosis and treatment for HCM.
Salix Coronary Plaque is primarily for Cardiology and Radiology specialties. Viz HCM is designed for Cardiology, Emergency Medicine, and Hospital Medicine specialties.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Salix Coronary Plaque or Viz HCM

Backers

Who funded each tool's parent company.

Viz HCM

AI Tool Finder
AI-powered search. Results may not be comprehensive.